Assignee
RIGEL PHARMACEUTICALS INC
US·390 granted patents·99 pending applications·6,025 citations·filing 1997–2025
Top patents by PatentIndex Score
489 records- 0199US8853397B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Oct 7, 2014·45 cites·7 claims
- 0299US8822685B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Sep 2, 2014·43 cites·17 claims
- 0399US7820819B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Oct 26, 2010·87 cites·17 claims
- 0499US7655797B2Intermediates for making 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Feb 2, 2010·81 cites·21 claims
- 0599US7642351B22,4-Pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jan 5, 2010·105 cites·14 claims
- 0699US7589200B25-Fluoro-4N-phenyl-4-pyrimidineamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Sep 15, 2009·102 cites·18 claims
- 0799US7582648B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Sep 1, 2009·114 cites·3 claims
- 0899US7557210B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2003·Granted Jul 7, 2009·190 cites·16 claims
- 0999US7550460B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2007·Granted Jun 23, 2009·95 cites·18 claims
- 1099US7498435B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Mar 3, 2009·93 cites·21 claims
- 1199US7485724B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 3, 2009·119 cites·20 claims
- 1299US7452879B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Nov 18, 2008·110 cites·13 claims
- 1399US7449458B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Nov 11, 2008·108 cites·13 claims
- 1499US7435814B22,4-Pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Oct 14, 2008·94 cites·11 claims
- 1599US7332484B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Feb 19, 2008·146 cites·4 claims
- 1699US7329672B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Feb 12, 2008·130 cites·19 claims
- 1799US7329671B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Feb 12, 2008·147 cites·19 claims
- 1899US7122542B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Oct 17, 2006·218 cites·6 claims
- 1999US7060827B2Intermediates useful for making 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Jun 13, 2006·255 cites·11 claims
- 2098US11479543B2Heterocyclic RIP1 kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Oct 25, 2022·5 cites·3 claims
- 2198US8748597B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jun 10, 2014·30 cites·1 claims
- 2298US7906644B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Mar 15, 2011·46 cites·1 claims
- 2398US7825116B2N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediaminesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Nov 2, 2010·55 cites·8 claims
- 2498US7812029B1Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Oct 12, 2010·73 cites·23 claims
- 2598US7563892B1Prodrugs of 2,4 pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jul 21, 2009·52 cites·8 claims
- 2698US7560466B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jul 14, 2009·56 cites·11 claims
- 2798US7517886B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2003·Granted Apr 14, 2009·141 cites·28 claims
- 2898US7491732B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 17, 2009·105 cites·6 claims
- 2997US11407736B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·4 cites·8 claims
- 3097US10975064B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Apr 13, 2021·14 cites·18 claims
- 3197US10941134B2AMPK-activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Mar 9, 2021·18 cites·20 claims
- 3297US10377742B2AMPK-activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Aug 13, 2019·20 cites·21 claims
- 3397US7989448B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Aug 2, 2011·35 cites·20 claims
- 3497US7884111B22,4-pyrimidinediamine compounds and uses as anti-proliferative agentsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 8, 2011·75 cites·12 claims
- 3597US7858633B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Dec 28, 2010·66 cites·5 claims
- 3697US7834024B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Nov 16, 2010·59 cites·6 claims
- 3797US7803939B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Sep 28, 2010·77 cites·21 claims
- 3897US7538108B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted May 26, 2009·43 cites·19 claims
- 3997US7528242B2Methods and compositions comprising Renilla GFPRIGEL PHARMACEUTICALS INC·Filed 2005·Granted May 5, 2009·71 cites·3 claims
- 4097US6667152B2Method for selective inactivation of viral replicationRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Dec 23, 2003·73 cites·20 claims
- 4196US11584758B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Feb 21, 2023·5 cites·37 claims
- 4296US11332451B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted May 17, 2022·3 cites·13 claims
- 4396US10815206B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·16 cites·17 claims
- 4496US10590121B2Kinase inhibitors and methods for making and usingRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·10 cites·37 claims
- 4596US10259826B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Apr 16, 2019·6 cites·7 claims
- 4696US9913842B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·8 cites·28 claims
- 4796US7947698B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted May 24, 2011·55 cites·54 claims
- 4896US7915273B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Mar 29, 2011·33 cites·2 claims
- 4996US7754714B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·39 cites·24 claims
- 5096US7709482B2Polycyclic heteroaryl substituted triazoles useful as Axl inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2007·Granted May 4, 2010·34 cites·62 claims
Showing the top 50 of 489 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →